03 / COMPANIES
FROM IDEAS
TO ENTERPRISES.
Inocule Group develops its opportunities selectively—through operating businesses, research platforms, partnerships, licensing and future ventures.
Inocule Group develops its opportunities selectively—through operating businesses, research platforms, partnerships, licensing and future ventures.
Affordable medicines today. Advanced pharmaceutical capabilities tomorrow.
Exploring genetic medicine and technologies capable of addressing disease at its biological source.
Connecting the nervous system with electronics, computing and artificial intelligence.
Exploring the future of engineered tissues and biological replacement.
Restoring physical function through robotics, electronics, advanced materials and biology.
Exploring ways to restore the body’s own ability to repair and regenerate.
Operating business — Affordable medicines today. Advanced pharmaceutical capabilities tomorrow.
Future platform — Exploring genetic medicine and technologies capable of addressing disease at its biological source.
Future platform — Connecting the nervous system with electronics, computing and artificial intelligence.
Future platform — Exploring the future of engineered tissues and biological replacement.
Future platform — Restoring physical function through robotics, electronics, advanced materials and biology.
Future platform — Exploring ways to restore the body’s own ability to repair and regenerate.
Inocule Pharmaceuticals provides an operating foundation while the Group develops longer-term capabilities in genetic medicine, neurotechnology, bioprinting, bionics and regenerative medicine.